时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
研究问题
It should be noted that mitophagy has often been inferred from a range of readouts across the studies above, including changes in LC3-II/p62 abundance, mitochondrial marker loss, and reporter systems.；Because changes in general autophagy markers or in the steady-state abundance of mitophagy-related proteins alone do not necessarily reflect a bona fide increase in mitochondrial degradation (i.e., mitophagic flux),
方法
Of note, this taurine study was performed in cultured macrophages and was not conducted in an RA disease model.
核心结论
( ) demonstrated in collagen-induced arthritis (CIA) mice that mtSTAT3 overexpression significantly reduced arthritis scores, alleviated joint inflammation and osteochondral damage, and downregulated pro-inflammatory cytokines such as IL-17.；In addition, mitochondrial dynamics proteins of 49 kDa and 51 kDa (MiD49 and MiD51, collectively termed MiDs) are significantly upregulated in RA-FLS and patient serum, with expression levels positively correlated with clinical disease parameters ( ).；Conversely, p62 knockdown reduced the antioxidant response and increased pro-inflammatory cytokine secretion upon TNF-α stimulation.；Studies have shown that the mutation frequency of mtDNA in inflamed synovial tissue is significantly increased and positively correlated with the degree of visible synovial inflammation, vascularity, and the levels of tumor necrosis factor α (TNF-α) and…
局限
However, this study has certain limitations, including a small sample size, lack of in vivo animal experiments, and the need for further investigation into the specific molecular targets of kaempferol.；Because these two findings derive from distinct cell types (preosteoblasts versus synovial fibroblasts), they should be interpreted separately rather than treated as interchangeable evidence.
对本项目的价值
临床前机制证据，需评估物种外推与剂量可行性：营养感知—自噬—蛋白稳态轴决定干预窗口与剂量方案，是组合疗法的时间锚。 ｜ 价值分 1.6/5（★★☆☆☆）
全文来源
PubMed PMC JATS 全文（正文 40,367 字符，已过 DOI 逐字 + 题名指纹双重归属校验）
原文题录
- 英文标题：Research progress of mitophagy and its targeted therapeutic strategies in rheumatoid arthritis.
- 期刊与标识：Frontiers in immunology · PMID 42959626 · DOI 10.3389/fimmu.2026.1959419
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。